Kuo Bianchini Tong
Mr. Tong is president and founder of Quorum Consulting (San Francisco), where he works with his clients to understand how economic, financial, and reimbursement forces can be managed and how to influence product acceptance and utilization. Tong is an active member of numerous professional organizations and societies including the Academy of Managed Care Pharmacy, American Public Health Association, American Society for Blood and Marrow Transplantation, American Society of Clinical Oncology, Infectious Disease Society of America, International Society for Heart and Lung Transplantation, International Society for Pharmacoeconomics
and Outcomes Research, and Society for Investigative Dermatology. Prior to founding Quorum Consulting, Tong was a senior associate with Corning HTA (now known as Covance; Washington, DC), a healthcare consulting firm. Prior to entering the consulting field, he was active in
clinical and health services research at the University of California at Los Angeles neuropsychiatric institute and the University of Pennsylvania department of medicine.
Tong holds a BA from the University of Pennsylvania and an MS in business and management from Johns Hopkins University.
Quorum Consulting
Since 1996, we’ve made it our business to understand the economic, reimbursement and financial issues that affect the success of new medical technologies. Which is why our clients include innovative pharmaceutical, biotechnology, medical device, and molecular diagnostic companies. Whether creating marketing and pricing strategies for early-stage medical technologies or developing and operating patient access programs, Quorum Consulting can help you deliver products and services to your key customers—patients, providers and third-party payers. http://www.quorumconsulting.com/